Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

The intragraft vascularized bone marrow component plays a critical role in tolerance induction after reconstructive transplantation.

Lin CH, Anggelia MR, Cheng HY, Wang AYL, Chuang WY, Lin CH, Lee WPA, Wei FC, Brandacher G.

Cell Mol Immunol. 2019 Nov 21. doi: 10.1038/s41423-019-0325-y. [Epub ahead of print]

PMID:
31754236
2.

Combined Anti-CD154/CTLA4Ig Costimulation Blockade-Based Therapy Induces Donor-Specific Tolerance to Vascularized Osteomyocutaneous Allografts.

Lin CH, Wang YL, Anggelia MR, Chuang WY, Cheng HY, Mao Q, Zelken JA, Lin CH, Zheng XX, Lee WP, Brandacher G.

Am J Transplant. 2016 Jul;16(7):2030-41. doi: 10.1111/ajt.13694. Epub 2016 Feb 23.

3.
4.

Composite osseomusculocutaneous sternum, ribs, thymus, pectoralis muscles, and skin allotransplantation model of bone marrow transplantation.

Bozkurt M, Klimczak A, Nasir S, Zor F, Krokowicz L, Siemionow M.

Microsurgery. 2013 Jan;33(1):43-50. doi: 10.1002/micr.22023. Epub 2012 Jul 23.

PMID:
22821819
5.

Effect of the vascularized bone components on the survival of vascularized composite allografts.

Chen J, Zhang D, Zhang T, Chen C, Song Y, Liu S, Su Y, Guo S.

J Surg Res. 2018 Apr;224:132-138. doi: 10.1016/j.jss.2017.03.050. Epub 2017 Apr 6.

PMID:
29506828
6.

A novel rat full-thickness hemi-abdominal wall/hindlimb osteomyocutaneous combined flap: influence of allograft mass and vascularized bone marrow content on vascularized composite allograft survival.

Ramirez AE, Cheng HY, Lao WW, Wang YL, Wen CJ, Wallace CG, Lin CF, Shih LY, Chuang SH, Wei FC.

Transpl Int. 2014 Sep;27(9):977-86. doi: 10.1111/tri.12364. Epub 2014 Jul 29.

7.

Long-term acceptance of composite tissue allografts through mixed chimerism and CD28 blockade.

Foster RD, Pham S, Li S, Aitouche A.

Transplantation. 2003 Sep 27;76(6):988-94.

PMID:
14508367
8.

The reversed paradigm of chimerism induction: Donor conditioning with recipient-derived bone marrow cells as a novel approach for tolerance induction in vascularized composite allotransplantation.

Siemionow M, Rampazzo A, Gharb BB, Cwykiel J, Klimczak A, Madajka M, Nasir S, Bozkurt M.

Microsurgery. 2016 Nov;36(8):676-683. doi: 10.1002/micr.30041. Epub 2016 Mar 14.

PMID:
26990895
9.

Tolerance to vascularized composite allografts in canine mixed hematopoietic chimeras.

Mathes DW, Hwang B, Graves SS, Edwards J, Chang J, Storer BE, Butts-Miwongtum T, Sale GE, Nash RA, Storb R.

Transplantation. 2011 Dec 27;92(12):1301-8. doi: 10.1097/TP.0b013e318237d6d4.

10.

Trafficking of donor-derived bone marrow correlates with chimerism and extension of composite allograft survival across MHC barrier.

Ozmen S, Ulusal BG, Ulusal AE, Izycki D, Yoder B, Siemionow M.

Transplant Proc. 2006 Jun;38(5):1625-33.

PMID:
16797371
11.

Biologics and donor bone marrow cells for targeted immunomodulation in vascularized composite allotransplantation: a translational trial in swine.

Wachtman GS, Wimmers EG, Gorantla VS, Lin CH, Schneeberger S, Unadkat JV, Zheng XX, Brandacher G, Lee WP.

Transplant Proc. 2011 Nov;43(9):3541-4. doi: 10.1016/j.transproceed.2011.10.010.

PMID:
22099837
12.

Use of CTLA4Ig for induction of mixed chimerism and renal allograft tolerance in nonhuman primates.

Yamada Y, Ochiai T, Boskovic S, Nadazdin O, Oura T, Schoenfeld D, Cappetta K, Smith RN, Colvin RB, Madsen JC, Sachs DH, Benichou G, Cosimi AB, Kawai T.

Am J Transplant. 2014 Dec;14(12):2704-12. doi: 10.1111/ajt.12936. Epub 2014 Nov 13.

13.

CTLA4-Ig plus bone marrow induces long-term allograft survival and donor specific unresponsiveness in the murine model. Evidence for hematopoietic chimerism.

Pearson TC, Alexander DZ, Hendrix R, Elwood ET, Linsley PS, Winn KJ, Larsen CP.

Transplantation. 1996 Apr 15;61(7):997-1004.

PMID:
8623206
14.

Mesenchymal stem cells enhance the induction of mixed chimerism and tolerance to rat hind-limb allografts after bone marrow transplantation.

Pan H, Zhao K, Wang L, Zheng Y, Zhang G, Mai H, Han Y, Yang L, Guo S.

J Surg Res. 2010 May 15;160(2):315-24. doi: 10.1016/j.jss.2008.09.027. Epub 2008 Nov 4.

PMID:
19524257
15.

Long-term Tolerance Toward Haploidentical Vascularized Composite Allograft Transplantation in a Canine Model Using Bone Marrow or Mobilized Stem Cells.

Chang J, Graves SS, Butts-Miwongtum T, Sale GE, Storb R, Mathes DW.

Transplantation. 2016 Dec;100(12):e120-e127.

16.

Chimerism after vascularized limb versus bone marrow transplantation.

Cohen M, Mohanakumar T, Mackinnon SE, Tung TH.

J Reconstr Microsurg. 2006 Jul;22(5):375-84.

PMID:
16845620
18.
19.

Chimerism induction in vascularized bone marrow transplants augmented with bone marrow cells.

Arslan E, Klimczak A, Siemionow M.

Microsurgery. 2007;27(3):190-9.

PMID:
17326192

Supplemental Content

Support Center